Kathuria Tanvi, Saharan Renu, Dhankhar Sanchit, Mahajan Shushank, Beniwal Suresh Kumar, Chauhan Samrat, Dahiya Preeti, Verma Inderjeet, Yasmin Sabina
MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India- 133207.
Chitkara University Chitkara College of Pharmacy Rajpura India.
Curr Drug Saf. 2025 Feb 11. doi: 10.2174/0115748863362068250122102544.
BACKGROUND: In recent years, transdermal drug delivery systems (TDDS) have gained popularity as a non-invasive, patient-friendly medication delivery method. OBJECTIVE: This review article examines the latest transdermal medication delivery developments and breakthroughs. The review begins with a brief summary of transdermal medication administration, stressing the skin's barrier role and drug permeation methods. Novel materials and methods improve drug solubility, stability, and skin permeability in formulation technologies. METHODS: A literature review of the most recent innovations in TDDS, such as nano-based delivery systems, microneedles, and smart patches, was conducted. Major challenges of drug solubility, stability, and skin permeability were carefully discussed, along with the transdermal patch designs of new therapeutic applications in pain management, cardiovascular diseases, and hormone therapy. RESULTS: Transdermal medication delivery difficulties may be overcome via nano-based drug delivery systems, microneedle arrays, and smart patches. Furthermore, the paper discusses current advances in transdermal patch design for therapeutic applications, highlighting effective instances in pain management, cardiovascular illness, and hormone therapy. CONCLUSION: The article examines transdermal medication delivery regulations, safety, and patient compliance in addition to technological advances. The complete study in this review seeks to help academics, doctors, and pharmaceutical professionals understand transdermal drug delivery and its future. Understanding recent advances in this field can help stakeholders design more effective and patient-friendly transdermal drug delivery systems, enhancing treatment outcomes and patient well-being.
背景:近年来,经皮给药系统(TDDS)作为一种非侵入性、患者友好的给药方法而受到欢迎。 目的:这篇综述文章探讨了经皮给药的最新进展和突破。综述首先简要总结了经皮给药,强调了皮肤的屏障作用和药物渗透方法。新型材料和方法在制剂技术中提高了药物的溶解度、稳定性和皮肤渗透性。 方法:对TDDS的最新创新进行了文献综述,如基于纳米的给药系统、微针和智能贴片。仔细讨论了药物溶解度、稳定性和皮肤渗透性的主要挑战,以及在疼痛管理、心血管疾病和激素治疗等新治疗应用中的透皮贴剂设计。 结果:基于纳米的药物递送系统、微针阵列和智能贴片可以克服经皮给药的困难。此外,本文讨论了治疗应用中透皮贴剂设计的当前进展,突出了在疼痛管理、心血管疾病和激素治疗中的有效实例。 结论:除了技术进步外,本文还研究了经皮给药的法规、安全性和患者依从性。本综述中的完整研究旨在帮助学者、医生和制药专业人员了解经皮给药及其未来发展。了解该领域的最新进展可以帮助利益相关者设计更有效、患者友好的经皮给药系统,提高治疗效果和患者福祉。
Curr Drug Saf. 2025-2-11
Curr Drug Deliv. 2024-7-18
Curr Hypertens Rev. 2025-4-28
Drug Deliv Transl Res. 2021-8
Curr Pharm Biotechnol. 2024-8-22
Pharmaceutics. 2024-10-21
Recent Pat Nanotechnol. 2025